Studies of marine sulfated polymannuroguluronate on endothelial cell proliferation and endothelial immunity and related mechanisms.
暂无分享,去创建一个
Jing Li | Huashi Guan | Jian Ding | Huashi Guan | M. Geng | Lichun Wang | Meiyu Geng | Jian Ding | Lichun Wang | Jing Li | Hua-shi Guan
[1] G. Waksman,et al. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. , 1995, Science.
[2] G. Groenewegen,et al. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. , 1996, Blood.
[3] B. Olwin,et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.
[4] R. Odedra,et al. Low molecular weight angiogenesis factors. , 1991, Pharmacology & therapeutics.
[5] W. Rath,et al. Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer. , 2002, Pathology, research and practice.
[6] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.
[7] Harold E. Dvorak,et al. Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.
[8] M. Nugent,et al. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. , 2000, Biochemistry.
[9] D. Ingber,et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.
[10] M. Salmivirta,et al. Selectively Desulfated Heparin Inhibits Fibroblast Growth Factor-induced Mitogenicity and Angiogenesis* , 2000, The Journal of Biological Chemistry.
[11] G. Groenewegen,et al. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy , 1999, International journal of cancer.
[12] I. Clemmensen,et al. Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL‐8, PDGF and angiostatin in relation to vascular density of xenografts in vivo , 2000, International journal of cancer.
[13] J. Richie,et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.
[14] J. Michel,et al. Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices. , 2002, Journal of biomedical materials research.
[15] J. Folkman. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. , 1990, Cancer metastasis reviews.
[16] A. Griffioen,et al. Angiogenesis modulates the tumour immune response , 1998, International journal of experimental pathology.
[17] G. Zugmaier,et al. Polysulfated Heparinoids Selectively Inactivate Heparin‐Binding Angiogenesis Factors , 1999, Annals of the New York Academy of Sciences.
[18] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[19] R. Linhardt,et al. Nature of the interaction of heparin with acidic fibroblast growth factor. , 1993, Biochemistry.
[20] H. Nagawa,et al. Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. , 1994, Cancer research.
[21] D C Rees,et al. Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.
[22] M. Jaye,et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.
[23] J. Gamble,et al. A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. , 1988, Journal of immunological methods.
[24] K. Flanders,et al. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. , 1988, Growth factors.
[25] W. Risau,et al. Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.
[26] M. Klagsbrun. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. , 1992, Seminars in cancer biology.
[27] G. Groenewegen,et al. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. , 1996, Cancer research.